Alzheimer's Drug Discovery Foundation (ADDF)
The ADDF accelerates the discovery of drugs to prevent and treat Alzheimer's disease through research funding and portfolio management.
Detaljert introduksjon
The Alzheimer's Drug Discovery Foundation (ADDF) is dedicated to advancing the discovery of drugs to prevent and treat Alzheimer's disease. ADDF funds research programs focused on drug development, biomarkers, and prevention strategies. In 2024, ADDF catalyzed significant breakthroughs, including major investments in scalable blood tests and the cataloging of Alzheimer's biomarkers. The foundation also marked the 10th anniversary of the Goodes Prize and celebrated the FDA approval of Kisunla (Donanemab). ADDF's diverse portfolio is one of the largest worldwide, emphasizing lifestyle interventions and innovative diagnostics.
MerForskning
Youper: Artificial Intelligence For Mental Health Care.
Youper utilizes artificial intelligence to revolutionize mental health care, offering scalable solutions for providers, employers, payers, and life science companies. As the first responder for emotional health issues, Youper provides instant support and integrates seamlessly into existing care workflows.
SPM - Statistical Parametric Mapping
SPM is a free and open-source software package for the analysis of brain imaging data sequences, supporting fMRI, PET, SPECT, EEG, and MEG. Developed by Karl Friston at University College London, it aims to facilitate statistical analysis of functional imaging data.
lab.js – online research made easy
lab.js is a free, open-source online study builder for the behavioral and cognitive sciences, designed to make online research accessible and efficient.